KS

Kunnath Sibi

Director Designated Partner DIN 10017118
DIN 10017118 First appointment Aug 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Kunnath Sibi

Data last updated:

Kunnath Sibi was a Designated Partner at Ceumed Medical Devices Llp (2022–2024) and Additional Director at Indusgo Mobility And Technology (India) Private Limited (from 2022). The companies operate in Healthcare.

DIN 10017118
Primary Designation Designated Partner
Industry Healthcare
First Appointment 24 Aug 2022
Oldest Company Age 6 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner24 Aug 20222022Active
Additional Director10 Dec 20222020Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Indusgo Mobility And Technology (India) Private Limited
Ceumed Medical Devices Llp
Premium access

Shareholding and investment profile for Kunnath Sibi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kunnath Sibi

Kunnath Sibi was first appointed on 24 Aug 2022 as Designated Partner at Ceumed Medical Devices Llp.

Kunnath Sibi held 2 earlier board appointments: Ceumed Medical Devices Llp (Designated Partner, 24 Aug 2022 to 22 Nov 2024); Indusgo Mobility And Technology (India) Private Limited (Additional Director, from 10 Dec 2022).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available